Sort
326,823 grants matching “clinical trial”
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2020 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,573,596Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Children's Oncology Group Phase 1 / Pilot Consortium
$2,573,434Susan M Blaney · National Childhood Cancer Foundation · U01 · FY2007 · CA
Targeting the B Cell Response to Treat Antibody-Mediated Rejection
$2,573,144Stuart Johnston Knechtle · Duke University · U01 · FY2024 · AI
NHGRI/DIR Technology Transfer Program
$2,573,005Anna Solowiej · National Human Genome Research Institute · ZIK · FY2024 · HG
Translational Research in Breast Cancer
$2,572,807Baylor College Of Medicine · P50 · FY2004 · CA
1-Year Sustained Release Naltrexone Implant for the prevention of relapse to opioid dependence
$2,572,678Frank J Martin · Delpor, Inc. · UG3 · FY2019 · DA
Toward Safer Gene Therapy for Hemophilia A
$2,572,180Roland W. Herzog · Indiana University Indianapolis · P01 · FY2022 · HL
Collaborative Pediatric Critical Care Research Network
$2,572,115Kevin M Watt · University Of Utah · PL1 · FY2024 · HD
Acylovir to prevent HIV acquisition in HSV-2+persons
$2,571,932University Of Washington · R01 · FY2002 · AI
UCLA Center for AIDS Research (CFAR)
$2,571,006Jerome A. Zack · University Of California Los Angeles · P30 · FY2016 · AI
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
$2,570,283Zeljko Vujaskovic · University Of Maryland Baltimore · U19 · FY2020 · AI
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$2,570,235Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab
$2,569,903Joren C Madsen · Massachusetts General Hospital · U01 · FY2019 · AI
Novel Cord Blood-Derived Cellular Therapies
$2,569,848Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Mammalian Hibernation Research- A Path Towards a Center for Transformative Research in Metabolism
$2,569,646Kelly L Drew · University Of Alaska Fairbanks · P20 · FY2019 · GM
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$2,569,447Hildegund C. J. Ertl · Wistar Institute · U19 · FY2007 · AI
Imaging, Dosimetry and Radiobiology for α-particle Emitter Radiopharmaceutical Therapy
$2,569,180Ana Ponce Kiess · Johns Hopkins University · P01 · FY2025 · CA
Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men
$2,568,889Christian Grov · Graduate School Of Public Health And Health Policy · UG3 · FY2023 · AI
Advancing brain health research through male germline editing in marmosets
$2,568,733Brian Peter Hermann · University Of Texas San Antonio · U01 · FY2021 · DA
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,568,667Andrea L Cox · Johns Hopkins University · U19 · FY2025 · AI
Units for HIV/AIDS Clinical Trials Networks
$2,568,528Richard C. Reichman · University Of Rochester · U01 · FY2007 · AI
CANCER PREVENTION CLINICAL TRIALS AUDITING AND INFORMATICS SUPPORT
$2,568,428David Malloy · Technical Resources International, Inc. · N01 · FY2020 · CA
Breast Cancer Family Registry Cohort
$2,567,967Esther M John · Cancer Prevention Instit Of California · UM1 · FY2015 · CA